AxoGen, Inc. (AXGN) scores 36 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $16.41, representing a 48% premium to fair value. Quantitative score: 48/100. Qualitative score: 30/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.